Iovance cuts staff amid slow sales start for ‘TIL’ cell therapy
13 September, 2025
Arvinas, Pfizer reworking partnership on ‘Protac’ cancer drug
13 September, 2025
FDA lifts pause on Valneva’s chikungunya shot, but adds new limits
13 September, 2025
Lilly shares fall as obesity pill misses expectations in key trial
13 September, 2025
FDA to start new ‘precheck’ program to boost US drug production
13 September, 2025
Strand raises another $153M to make ‘programmable’ mRNA drugs
13 September, 2025
Elevidys sales weaken; Neumora gets into obesity
13 September, 2025
Inside AstraZeneca’s long-term strategy in lung cancer
13 September, 2025
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago